Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioharvest Sciences (BHST) EBIT Margin (2023 - 2025)

Historic EBIT Margin for Bioharvest Sciences (BHST) over the last 3 years, with Q3 2025 value amounting to 10.15%.

  • Bioharvest Sciences' EBIT Margin rose 220000.0% to 10.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 18.77%, marking a year-over-year increase of 823700.0%. This contributed to the annual value of 27.75% for FY2024, which is 509000.0% up from last year.
  • Latest data reveals that Bioharvest Sciences reported EBIT Margin of 10.15% as of Q3 2025, which was up 220000.0% from 21.32% recorded in Q2 2025.
  • Over the past 5 years, Bioharvest Sciences' EBIT Margin peaked at 104.55% during Q2 2023, and registered a low of 384.58% during Q4 2023.
  • Its 3-year average for EBIT Margin is 38.28%, with a median of 22.52% in 2024.
  • Data for Bioharvest Sciences' EBIT Margin shows a peak YoY increase of 3614000bps (in 2024) and a maximum YoY decrease of -1340100bps (in 2024) over the last 5 years.
  • Over the past 3 years, Bioharvest Sciences' EBIT Margin (Quarter) stood at 384.58% in 2023, then surged by 94bps to 23.18% in 2024, then soared by 56bps to 10.15% in 2025.
  • Its EBIT Margin was 10.15% in Q3 2025, compared to 21.32% in Q2 2025 and 21.87% in Q1 2025.